I am lucky enough to take a week off from the Canadian fall and coming winter (especially with the NHL lockout) to head down to tropical Miami to attend the Transcatheter Cardiovascular Therapeutics (TCT) conference. It is expected to be the biggest one yet, attracting over 12,000 attendees with two-thirds coming from outside the US. Best practices, late-breaking clinical trials, and new cardiovascular technologies will all take center stage at the Miami conference center. The problem is, there is just too much to take in?the modern interventional cardiologist has to walk a fine line in choosing which seminars and talks to attend.

While interventional cardiology remains the center piece of the conference, the number of talks focused on structural heart stuff (transcatheter heart valves, patent foramen ovale [PFO] closure, mitral procedures), the peripheral vasculature, and the new kid on the block, renal denervation, continues to grow. With interventional cardiologists moving into new fields it must be a pain trying to choose between two interesting talks? ?Do I check out the late-breaking PFO trials or do I hit up that TAVI talk??

This really shows the diversity of procedures that we are now seeing in the cath lab, representing the continued transition from surgical procedures to minimally invasive cath procedures. For me, it means scrambling between different conference rooms to catch as many of the key talks as I can. My suggestion (not at all influenced by the fact that it's in Miami) would be to lengthen the conference so that I don?t have to miss anything?actually, while we?re at it, how about they set up a big projector on the beach?talks by the ocean wouldn?t be too bad!

See you in Miami!

Stay updated with the latest new from the conference by following the twitter hashtag #TCT2012 or MRG on twitter http://twitter.com/MillenniuMRG.

DRG becomes Clarivate

View Now